Table 3.
Adherence Rationale by Reported Adherence and Clinical Outcomes at T1 and T4 (n=80)
| |
T1 |
T4 |
||||
|---|---|---|---|---|---|---|
| Reported adherence (mean %±SD) | Median CD4 (cells/μL) (min, max) | Median viral load (copies/mL) (min, max) | Reported adherence (mean %±SD) | Median CD4 (cells/μL) (min, max) | Median viral load (copies/mL) (min, max) | |
| Authoritative Knowledge Rationale (n=29) | 88.7±18.4a | 380a (5–992) | 694 (50–447k) | 76.0±23.8a | 450a (7–1029) | 400 (50–750k) |
| Doctor's Orders Rationale (n=24) | 84.5±16.4a | 339a (34–968) | 1974 (50–650k) | 76.5±20.7a | 440a (90–897) | 400 (50–30k) |
| Individual Adherence Rationale (n=27) | 79.9±21.5 | 242 (5–2500) | 725a (40–750k) | 66.4±21.5 | 315 (8–999) | 10,000a (50–750k) |
a
p<0.05 (comparisons between T1 and T4).
SD, standard deviation.